menu
    • menu

    Company profile for Angion Biomedica

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Angion BiomedicaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    456 Montgomery Street, Suite 1200 San Francisco, CA 94104
    Telephone
    Telephone
    (415) 655-4899
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://angion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/angion/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AngionBiomedica

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
    Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split

    01 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/01/2680276/0/en/Angion-Biomedia-Corp-Announces-1-for-10-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    01 Jun 2023
    Share Share
    Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
    Elicio Therapeutics and Angion Enter into Definitive Merger Agreement

    17 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/17/2589654/0/en/Elicio-Therapeutics-and-Angion-Enter-into-Definitive-Merger-Agreement.html

    GLOBENEWSWIRE
    17 Jan 2023
    Share Share
    Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica
    Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica

    17 Jan 2023

    // BIOSPACE

    https://www.biospace.com/article/kras-vaccine-updates/?s=79

    BIOSPACE
    17 Jan 2023
    Share Share
    Cancer vaccine developer jumps to Nasdaq via reverse merger
    Cancer vaccine developer jumps to Nasdaq via reverse merger

    17 Jan 2023

    // Amber Tong ENDPTS

    https://endpts.com/elicio-cancer-vaccine-angion-reverse-merger/

    Amber Tong ENDPTS
    17 Jan 2023
    Share Share
    Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
    Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

    21 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/22/2578302/0/en/Angion-Receives-Nasdaq-Notice-Regarding-Minimum-Bid-Price-Requirements.html

    GLOBENEWSWIRE
    21 Dec 2022
    Share Share
    Angion Reports Second Quarter 2022 Financial Results
    Angion Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/15/2498535/0/en/Angion-Provides-Corporate-Update-and-Reports-Second-Quarter-2022-Financial-Results.html

    GLOBENEWSWIRE
    15 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search